NA

NewEdge Advisors Portfolio holdings

AUM $22B
1-Year Est. Return 20.34%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+20.34%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$22B
AUM Growth
+$2.6B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
4,282
New
Increased
Reduced
Closed

Top Buys

1 +$62.3M
2 +$57.6M
3 +$56.7M
4
QQQ icon
Invesco QQQ Trust
QQQ
+$44.2M
5
QCOM icon
Qualcomm
QCOM
+$43.3M

Top Sells

1 +$58.7M
2 +$37.8M
3 +$36.7M
4
SNY icon
Sanofi
SNY
+$31.5M
5
AAPL icon
Apple
AAPL
+$25.9M

Sector Composition

1 Technology 15.23%
2 Financials 6.81%
3 Consumer Discretionary 4.31%
4 Communication Services 3.48%
5 Industrials 3.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EGBN icon
4251
Eagle Bancorp
EGBN
$806M
-83
HTUS icon
4252
Hull Tactical US ETF
HTUS
$137M
-100
PMF
4253
DELISTED
PIMCO Municipal Income Fund
PMF
-7,290
PMX
4254
DELISTED
PIMCO Municipal Income Fund III
PMX
-49,100
PSBD icon
4255
Palmer Square Capital BDC
PSBD
$369M
-1,587
PSCI icon
4256
Invesco S&P SmallCap Industrials ETF
PSCI
$159M
-6
PVAL icon
4257
Putnam Focused Large Cap Value ETF
PVAL
$7.6B
-6,310
REAX icon
4258
Real Brokerage
REAX
$758M
-12,314
RELY icon
4259
Remitly
RELY
$2.8B
-25,848
RGS icon
4260
Regis Corp
RGS
$58.3M
-555
SAR icon
4261
Saratoga Investment
SAR
$384M
-358
SDGR icon
4262
Schrodinger
SDGR
$1.05B
-1
SGLC icon
4263
SGI US Large Cap Core ETF
SGLC
$125M
0
STRO icon
4264
Sutro Biopharma
STRO
$127M
-411
SUPV
4265
Grupo Supervielle
SUPV
$1.12B
-14,625
SWTX
4266
DELISTED
SpringWorks Therapeutics
SWTX
-225
SYPR icon
4267
Sypris Solutions
SYPR
$71.2M
-150
SZNE icon
4268
Pacer CFRA-Stoval Equal Weight Seasonal Rotation ETF
SZNE
$12.8M
-34,007
ABR icon
4269
Arbor Realty Trust
ABR
$1.54B
-540
ABVX
4270
Abivax
ABVX
$8.91B
-30,000
AC
4271
DELISTED
Associated Capital Group
AC
-318
AGD
4272
abrdn Global Dynamic Dividend Fund
AGD
$310M
-48,303
AMED
4273
DELISTED
Amedisys
AMED
-13
AMPY icon
4274
Amplify Energy
AMPY
$204M
-650
AMRX icon
4275
Amneal Pharmaceuticals
AMRX
$4.44B
-5